Projects We Have Joined

Participation in Global Health Innovative Technology Fund (GHIT Fund)

News Release: Chugai - A*STAR Joint Development Project for Anti-Dengue Virus Antibody Continuously Selected as Grant Recipient by GHIT Fund (Mar. 29, 2019)

News Release: Participation in the Global Health Innovative Technology Fund (GHIT Fund) (Dec. 24, 2014) [PDF 120KB]

GHIT Fund is a public-private partnership to support research and development of pharmaceuticals, vaccines and diagnostics for serious diseases in developing countries. It utilizes Japan’s medical technology, innovation and knowledge more directly. ()

Participation in Access Accelerated

News Release: Chugai to Join Global Initiative for Addressing Rise of Non-Communicable Diseases in Low and Lower-Middle Income Countries (Jan. 18, 2017)

To work on the United Nations Sustainable Development Goal to reduce premature deaths from non-communicable diseases (NCDs) by one-third by 2030, 22 leading global biopharmaceutical companies launched Access Accelerated. It is a global initiative to advance access to NCD prevention information, diagnosis and care in low and middle-income countries. ()

Participation in WFH (World Federation of Hemophilia) Humanitarian Aid Program

News Release: Together with Roche, Chugai Joins the World Federation of Hemophilia Humanitarian Aid Program (Feb. 06, 2019)

WFH Humanitarian Aid Program is a landmark initiative leading the effort to improve access to care and treatment for people with inherited bleeding disorders in developing countries where access to treatment is limited.

  • E-mail

Global Health

Back to top